Chronic hepatitis B virus infection results in a spectrum of disease entities ranging from the most severe form of chronic active hepatitis to the asymptomatic carrier state of the Hepatitis B surface antigen (HBS Ag). This wide range of liver injury among chronically infected hepatitis B virus (HBV) patients suggests a great degree o f variability in the interaction between the replicating virus and the immune responses to the infected hepatocyte7. It is well known that HBV -specific liver cell injury, and subsequent viral clearance, is believed to be mediated mainly by cellular immune mechanisms6.
Patients with chronic HBV infection can be generally divided into two groups:
A) Those with chronic liver disease (usually referred to as having chronic type B hepatitis [CHB] ). These patients have markers of active viral replication, such as hepatitis Be antigen (HBe Ag) or HBV-DNA in serum or hepatitis Bc antigen (HBC Ag) in the liver, in addition to abnormal serum alanine aminotransferase (ALT) activities and detectable HBS Ag in serum and liver.
B) Those without liver disease, referred to as being in a "healthy" or "inactive" HBg Ag carrier state. These patients have HBg Ag, but without HBV-DNA or HBe Ag in serum, or detectable HBC Ag and HBg Ag in the liver, having, usually, normal serum ALT levels, no active inflammation or hepatocellular necrosis in the liver biopsies9. Studies on the natural history of chronic HBV infection indicate that these two groups probably represent two stages of chronic HBV infection: either spontaneously or during treatment, patients with CHB can lose HBV-DNA and HBe Ag from serum and then have a remission with subsequent appearance of antibody to HBe Ag (anti-HBg). In this case, the disease usually evolves from chronic hepatitis to the "healthy" HBg Ag carrier state. Seroconversion from HBe Ag to anti-HBe is thus a "critical" event in the natural history of chronic HBV infection, and can occur directly after the acute phase (acute hepatitis) or it may happen years later, often following a flare-up of symptoms and increase in the ALT levels, or, in other words, presenting as an acute exacerbation in the evolution of a chronic hepatitis9.
A large percentage of patients with chronic . active hepatitis (CAH) show a ciclic pattern characterized by acute exacerbations of liver injury alternating with normal liver function, suggesting a dynamic interaction between the virus replication and the immune response6. Acute exacerbations in chronic B hepatitis are usually defined as episodes of abrupt elevation of ALT with or without significant symptom aggravation. Persistence of HBe Ag after spontaneous flares is referred to as "abortive seroconversion"9.
We describe a case of an acute exacerbation of liver injury in a chronic HBV infected young male who probably acquired the disease in the neonatal or early childhood period, and was asymptomatic before this episode of acute exacerbation. Others causes of hepatitis were excluded by the available commercial assays and a percutaneous liver biopsy especimen was analised using immunohistochemical techniques.
CASE REPORT
HAF, a 15-year-old young male, natural from São Paulo -Brazil, looked for medical attention in April, 19 1994, with a 2 week history of right upper quadrant pain, jaundice, dark urine and a 4 day history of lethargy and change in personality. He denied fever, headache, diarrhoea, and his past medical history was unremarkable. There was no history o f digestive or hepatic symptoms in the past. He denied intravenous drug addiction, sexual activity, previous blood transfusions, recent travel, as well as previous use of medications or exposure to toxins. The physical examination revealed an acutely ill, well developed patient with jaundice, without signs of chronic liver disease such as spiders, hepatomegaly, splenomegaly or ascites. The cardiac and pulmonary exam ination was normal. He was lethargic, confused, but there were no focal neurologic deficits, seizures or meningismus. The laboratory findings at admission and the serologic pattern are listed below:
ALT -1621 U/L (0-18 U/L) Bilirubin total -17.2mg/dL conjugated = 12.3mg/dL Protein total = 6.0g/dL Aibumin -3.9g/dL
• a 1 globulin * 0.2g/dL • a 2 globulin * 0.4g/dL Evolution. The patient was admitted to the intensive care unit and received supportive care for hepatic insufficiency, with prompt improvement in the level of consciousness. There were no bleeding complications, and the hepatic function improved to a level that an emergency hepatic transplantation was unnecessary. A percutaneous liver biopsy was done on May, 25 , 1994 and the hepatic tissue evidenced extense areas of bridging necrosis, either between portal zones or from portal zones to central veins. These necrotic areas had their reticulin framework colapsed and their hepatocytes had disappeared. The portal zones showed a moderate mononuclear cell infiltrate, without piecem eal necrosis or aggression to the bile ducts. A small number of neutrophils was also observed in the portal z o n e s and n e c r o t ic a re a s . B a llo o n in g degeneration, without evident aspect of ground-glass cell could also be noted in the preserved parenchyma. There was a discrete hypertrophy and hyperplasy of the Kupffer cells. No portal fibrosis was observed. The immunohistochemical technique revealed a small number of hepatocytes (less than 25%) positive to HBS Ag and an absence of HBC Ag or HDV Ag (antigen of the Hepatitis Delta Virus). At the time of the first biopsy, serum was collected and the PCR for HBV-DNA was negative.
Bridging necrosis found during acute viral hepatites indicates a serious lesion that can progress to postnecrotic cirrhosis or to "restitutio ad integrum ". B eca u se o f this, an oth er percutaneous liver biopsy was done 6 months after discharge (on December, 1 2^ ,1994), and the specimen showed a practically normal hepatic architecture. The hepatocytes had no sign of degeneration or necrosis. The portal zones were not expanded and evidenced a mild limphocytic infiltration, which was also ocasionally observed in the lobular spaces. The hypertrophy and hiperplasy of Kupffer cells remained discrete. A small strip of intralobular fibrosis could be observed.The immunohistochemical technique had similar results when compared to the first examination: few hepatocytes expressing HBS Ag and an absence of HBC Ag. The serological pattern for markers of HBV persisted exactly the same during the six month period of follow-up, with normalizaton of laboratory tests of hepatic function.
DISCUSSION
The serological pattern for markers of HBV, caracterized by the absense of detectable anti HBc-IgM ruled out acute-phase infection by HBV5, as well as the negative results of IgM anti-HAV, anti-HCV antibodies and PCR for HCV-RNA in serum, antibody to HDV (anti-H D V ) a n d t h e n e g a t i v e r e s u l t o f immunohistochemical for HDV in the liver biopsy ruled out superinfections with other hepatotropic virus. The laboratory tests currently used for diagnosis of hepatitis E virus were not available at the time of patient illness : a serum sample was stored and tested retrospectively for antibodies to this new described virus, giving a negative reaction by the method of Elisa.
The serologic tests for intection with other non hepatotropic virus such as cytomegalovirus, Epstein-Barr virus were negative.
The absence of markers of viral replication of HBV virus (HBg Ag and HBV-DNA) in serum and the presence of anti-HBe , in addition to the absence of HBC Ag in the liver indicates that active viral replication is subsiding and disease activity decreasing. Because those who have cleared HBg Ag frequently have temporary e x a c e rb a tio n s o f h ep a titis b e fo re the seroconversion, it has been suggested this event represents an "immune clearance" of hepatocytes containing actively replicating virus as well as HBc Ag/HBe Ag6 7 9.
The nucleocapside antigens of HBV (in the context of HLA antigens) are the most important target for cytoxicity. Recent studies on T cell response to HBV antigens during acute exacerbations of CHB demonstrated that the T cell proliferative response to recombinant HBC Ag and natural HBe Ag was higher in patients with CHB than those in healthy HBg Ag carriers, and that there was a further increase in T cell proliferative response to HBC Ag/HBe Ag during acute exacerbations. In the recovery from th ese acute ex acerb atio n s w ith H Be Ag seroconvertion, the same study demonstrated a subsidence in T cell responses to the same antigens9.
Studying the alterations in quantitative serum HBV-DNA, HBe Ag (as indicators of viral replication) and anti-HBg production, HBe Ag specific immunocomplex formation (as indicators o f an immune responsiveness) before, during and after injury in HBe Ag positive patients with CAH, Maruyama et al6 showed that the increasing levels of viral replication occurred b efo re the p eak ALT levels, and then precipitously declined as ALT levels peaked and subsided. The indicators of immune responsiveness (anti-HBe and HBg Ag specific immuno complex) increased in parallel with HBV-DNA/HBe Ag levels, with the exception of the anti-HBe antibody, that peaked somewhat later than HBV-DNA/HBp Ag. The ability to produce anti HBe reflects the immune competence of these patients with CAH, at least with respect to the HBe Agspecific helper T cells and B cells, and is consistent with the possibility that the liver cell injury is mediated by immune mechanisms.
Another diagnostic possibility in this case is the existence of HBV precore mutants. Variants of HBV that do not express HBe Ag have recently been described2 3. The most common is the G-to-A switch at base 1896 of HBV-DNA precore region. The emergence of this precore mutants has been associated with fulminant hepatitis and severe liver disease in patients with anti-HBe positive chronic hepatitis1. In these cases, other markers of viral replication (as HBV-DNA) are expected to be present, and that was not shown in the present report, making this hypothesis less probable.
In some circunstances, it can be difficult to distinguish between an acute HBV infection from an acute exacerbation of a chronic HBV infection. This is true because, in contrast to most viral infections, patients with acute and c h r o n ic H B V o f t e n p r o d u c e b o th immunoglobulin (Ig)M and IgG anti-HBc antibodies, and so, the quantitative difference in the levels of IgM anti-HBc (higher level of IgM anti HBC are generally produced during a c u te p h a s e in f e c t io n ) c a n b e th e o n ly serological means of differentiating this situation, what is important in terms of prognosis and possible treatment modalities7. Recent studies have focused on the serology of chronic HBV infections, using assays capable of detecting antibody to HBe Ag and HBS Ag in the presence of circulating HBe and HBg A g7. T h e u se o f th e s e e x p e r im e n ta l immunoassays has modified our view of the serology of chronic HBV infection by showing that virtually all HBV chronic carriers with liver disease are positive for both HBe Ag and antiHBe for many years before the loss o f HBg Ag, and anti-HBs production can be detected as HBS Ag -specific immune complexes (ICs) in parallel with liver damage in CAH patients7.
These same experimental assays, when applied to acute HBV infection reveal that patients with CHB show significantly higher levels of free anti-HBe , HBe Ag/anti-HBe ICs and HBS Ag/anti-HBs ICs compared with acute HBV patients sera. Furthermore, the most significant and possibly the most useful difference in the serology o f patients with acute and chronic HBV is the presence of a novel specificity of IgG anti-HBc antibody designated as anti WHBc antibodies. Previous studies have indicated that the nucleocapsides of HBV and the Woodchuck hepatitis virus (another mem ber of the Hepadnaviridae family) share a cross-reactive epitope(s). So, it is d em o n strated that hum an an ti-H B c antibodies recognize Woodchuck HBC Ag (WHBC Ag), and that CHB patient sera show significantly higher levels of IgG anti-WHBc compared with acute hepatitis B patient sera, without overlap values. The same authors propose a ratio o f IgM anti-HBc/'IgG anti-WHBC that could be performed in acute and chronic HBV infections in order to discriminate between acute hepatitis B from symptomatic chronic hepatitis B infection: an inverse correlation between IgM anti-HBc and IgG anti-WHBc values existed in both patients with acute and chronic HBV infection7.
Recent studies on the prevalence of HBS Ag subtypes (adr, adw, ayr and ayw) have demonstrated differences in their geographic distribution and their relationship with epidemiologic factors. More recently, HBS Ag subtypes have been associated with HBe Ag/anti HBe status and may, consequently, influence the development of liver disease in the HBS Ag carriers. For example, in a restricted geographic area o f Japan, with a homogenous epidemiological/cultural background, adr carriers tend to be seroconverted to anti-HBe at an older age than adw carriers, and thus, adr carriers may develop chronic liver disease more frequently than adw carriers8. Data on HBs Ag subtypes prevalence in our geographic region (São Paulo -Brazil) are not available, so, conclusions based in the HBS Ag subtype of our patient could not be done, and it was not determined.
Various average annual conversion rates for HBe Ag to anti-HBe have been reported in adults; these rates range from 2.3% to 25% in various parts of the world4. With respect to other factors affecting the clearance of HBe Ag specifically in children, studies have shown that the presence o f symptoms, a negative maternal HBg Ag status, and the infection occurring later in life, are correlated with a higher HBe Ag clearance rate4.
The patient reported in this review was a 14 years old boy that denied the most important risk factors related to HBV infection, including sexual activity. His mother serum was obtained and the biochem ical and serologic analysis revealed a normal hepatic function and a negative result for HBgAg with a positive result for anti-HBs and anti-HBc IgG antibodies, proving a previous contact with HBV with adquired resistance to HBV infection. So, it is possible to assume that our patient had probably been infected during the perinatal period by his mother, or during early childhood. At least, it is possible to infer that sometime in her life, the patient's mother had active HBV replication, and was able to transmit HBV to her infants or household contacts.
In conclusion, we postulate that the acute and serious ex a cerb a tio n o f liver injury presented here is related to the immune clearance of hepatocytes expressing HBV nucleocapside antigens acumulated intracellularly after a period of increased replication. Probably, as the serum HBe Ag concentration reached a threshold level, H Be/HBc Ag specific TH cells became activated, resulting in anti-HBe production. Similarly, HB"/HBC Agspecific citotoxic T lymphocytes & TL) were induced, favoring cell-mediated immunity and r e s u lte d in an e f f ic ie n t v ira l c le a r a n c e m e c h a n ism o f h e p a to c y te s p ro d u c in g nucleocapside antigens, but sparing the hepatocytes exclusively producing HBg Ag, r e s u l t i n g in a n i m p r o v e m e n t o f clinicai/laboratorial and histopathologic findings, with change to the "healthy" HBS Ag carrier state.
RESUMO
Descreve-se um caso de exacerbação aguda sintomática em um p a cien te cronicam ente infectado pelo VHB, mostrando-se correlação entre o quadro clínico grave (com insuficiência hepática transitória) e os achados histopatológicos de hepatite severa com extensas áreas de necrose em ponte. O perfil sorológico para marcadores do VHB (Ag HBS +, anti HBS Ag HBe -, anti HBe +, anti HBC IgG + IgM -) confirmou infecção crônica, e os autores levantam a hipótese de que a hepatite tenha se coiTelacionado â recente soroconversão Ag HBe para anti-HBe. Outras etiologias possíveis foram descartadas e se contou com biópsia controle 6 meses depois, mostrando norm alização da arquitetura hepática e ausência de marcadores de replicação viral no tecido e no soro. Revisa-se a literatura sobre o diagnóstico diferencial cabível nesta situação, dando ênfase a novos ensaios sorológicos úteis na diferenciação entre infecção aguda pelo VHB e exacerbação aguda de uma hepatite crônica pelo mesmo agente. P a la v ra s-ch a v es: E x a c e rb a ç ã o a g u d a . Soroconversão AgHBe-anti Hb^ Infecção crônica pelo VHB.
